The New Endothelin Receptor Antagonist Macitentan: Prospects for Therapy of Pulmonary Arterial Hypertension
Terapevticheskii Arkhiv - Russian Federation
doi 10.17116/terarkh201688789-97
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Media Sphere Publishing Group